Accessibility Menu
Tecan Group Ag logo

Tecan Group Ag(OTC) TCHBF

Market Cap$3.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)+770%
5 Year-54%
1 Year+22%
1 Month+27%
$238.90
+0.00%
+0.00Today
Tecan Group Ag last closing stock price
MetricPriceDate
Last closeUSD 252.062026-08-05
Tecan Group Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+11.7%USD 225.652026-07-10
1 month+27.3%USD 198.002026-06-25
3 month+45.01%USD 173.822026-04-17
Year to date+61.72%USD 155.862025-12-26
1 year+21.77%USD 206.992025-07-23
3 year-29.54%USD 357.732023-07-25
5 year-53.96%USD 547.442021-08-02
Since inception+769.96%USD 28.972005-01-31

Tecan Group Ag Financials at a Glance

Market Cap

$3.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CHF 1.77B

Net Income (TTM)

-CHF 53.31M

EPS (TTM)

-$11.43

P/E Ratio

-22.05

Dividend

$1.93

Beta (Volatility)

-0.02 (Low)

Price

$238.90

Volume

34

Open

$238.90

Previous Close

$252.06

Daily Range

$238.90 - $238.90

52-Week Range

$155.25 - $252.06

Estimated Earnings Date

Mar 16, 2027

TCHBF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tecan Group Ag

Tecan Group AG is a specialized provider of advanced laboratory instruments and comprehensive solutions, catering to pharmaceutical and biotechnology firms, academic research institutions, and diagnostic testing facilities. Established in 1980 and headquartered in Männedorf, Switzerland, Tecan operates globally, offering innovative products that enhance laboratory efficiency and accuracy.

Products and Services
  • Automated liquid handling systems for precise sample management
  • Next-generation sequencing reagents and immunoassays for advanced diagnostics
  • Comprehensive software solutions for laboratory automation and data analysis
Growth Outlook
  • Revenue of CHF 443.2 million in Q4 2025, showing strong market demand
  • Operating income margin improved to 4.8% in Q4 2025, indicating operational efficiency
  • Continued investment in R&D, with CHF 33.3 million allocated in Q4 2025
Financial Highlights
  • Net income of CHF -128.6 million in Q4 2025, reflecting recent challenges
  • Cash and short-term investments totaled CHF 311.4 million as of Q4 2025
  • Dividend yield of 1.54% TTM, demonstrating commitment to shareholder returns
Tecan Group AG has established itself as a leader in the medical diagnostics and research industry, providing essential tools and solutions that support scientific advancement. The company's diverse product portfolio and commitment to innovation position it well for future growth, despite recent financial challenges. The focus on R&D and operational efficiency suggests a proactive approach to navigating market dynamics. With a solid cash position and a commitment to dividends, Tecan remains an intriguing option for investors interested in the healthcare sector.
AI Generated • Aug 10, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

3,244

CEO

Monica Del Carmen Manotas Urueta, MBA

Website

www.tecan.com

Headquarters

Männedorf, ZH 8708, CH

TCHBF Financials

Key Financial Metrics (TTM)

Gross Margin

34.06%

Operating Margin

4.60%

Net Income Margin

-13.36%

Return on Equity

-10.25%

Return on Capital

1.84%

Return on Assets

-7.06%

Earnings Yield

-4.54%

Dividend Yield

0.76%

Payout Ratio

-31.97%

Stock Overview

Market Cap

$3.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

12.72M

Volume

34

Avg. Volume

16.254

Financials (TTM)

Gross Profit

CHF 614.79M

Operating Income

CHF 112.72M

EBITDA

CHF 241.39M

Operating Cash Flow

CHF 260.11M

Capital Expenditure

-CHF 68.08M

Free Cash Flow

CHF 192.03M

Cash & ST Invst.

CHF 223.37M

Total Debt

CHF 213.12M

Tecan Group Ag Performance Analysis

Tecan Group Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CHF 1,198,097,36615.7%
20232023-12-31CHF 1,195,553,226-0.2%
20242024-12-31CHF 1,060,874,766-11.3%
20252025-12-31CHF 1,062,606,4070.2%
Tecan Group Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-0.0%
Q22025-06-30-5.9%
Q42025-12-310.9%
Q22026-06-30-4.1%
Tecan Group Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CHF 9.92-8.2%
20232023-12-31CHF 11.4615.6%
20242024-12-31CHF 6.01-47.6%
20252025-12-31CHF -10.52N/A
Tecan Group Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31102.3%
Q22025-06-30-60.2%
Q42025-12-31-819.9%
Q22026-06-30109.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CHF 425.12M

-9.0%

Gross Profit

CHF 144.12M

-10.4%

Gross Margin

33.90%

N/A

Market Cap

$3.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$988.02K

N/A

Employees

3,244

N/A

Net Income

CHF 12.20M

-45.7%

EBITDA

CHF 46.48M

-12.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CHF 223.37M

-35.0%

Total Debt

CHF 213.12M

-32.5%

Accounts Receivable

CHF 195.97M

+7.1%

Inventory

CHF 217.42M

-22.5%

Long Term Debt

CHF 202.82M

-33.3%

Short Term Debt

CHF 10.30M

-10.5%

Return on Assets

-7.06%

N/A

Return on Invested Capital

2.93%

N/A

Free Cash Flow

CHF 11.20M

-71.8%

Operating Cash Flow

CHF 17.02M

-60.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANSLYAnsell Limited
$84.09+0.00%
DSRLFDiaSorin S.p.A.
$85.47+0.00%
SDMHFSartorius Stedim Biotech S.A.
$208.48+3.67%
SAUHFStraumann Holding AG
$128.25+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.00+0.08%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.77+0.01%
ONDSOndas
$9.23+0.04%
SPCXSpace Exploration Technologies
$139.99-0.01%

Questions About TCHBF

What is the current price of Tecan Group Ag?

Tecan Group Ag is trading at $238.90 per share.

What is the 52-week range for Tecan Group Ag?

Over the past 52 weeks, Tecan Group Ag has traded between $155.25 and $252.06.

How much debt does Tecan Group Ag have?

As of the most recent reporting period, Tecan Group Ag reported total debt of CHF 275.93M.

How much cash does Tecan Group Ag have on hand?

Tecan Group Ag reported CHF 222.62M in cash and cash equivalents in its most recent financial results.

What is Tecan Group Ag’s dividend yield?

Tecan Group Ag currently has a dividend yield of 0.76%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services